| Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene ND Merner, KA Hodgkinson, AFM Haywood, S Connors, VM French, ... The American Journal of Human Genetics 82 (4), 809-821, 2008 | 582 | 2008 |
| The changing landscape for stroke prevention in AF: findings from the GLORIA-AF registry phase 2 MV Huisman, KJ Rothman, M Paquette, C Teutsch, HC Diener, SJ Dubner, ... Journal of the American College of Cardiology 69 (7), 777-785, 2017 | 338 | 2017 |
| The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5) KA Hodgkinson, PS Parfrey, AS Bassett, C Kupprion, J Drenckhahn, ... Journal of the American College of Cardiology 45 (3), 400-408, 2005 | 237 | 2005 |
| Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society … MH Gollob, L Blier, R Brugada, J Champagne, V Chauhan, S Connors, ... Canadian Journal of Cardiology 27 (2), 232-245, 2011 | 183 | 2011 |
| Values and preferences of physicians and patients with nonvalvular atrial fibrillation who receive oral anticoagulation therapy for stroke prevention JG Andrade, AD Krahn, AC Skanes, D Purdham, A Ciaccia, S Connors Canadian Journal of Cardiology 32 (6), 747-753, 2016 | 128 | 2016 |
| The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p. S358L mutation in TMEM43 KA Hodgkinson, SP Connors, N Merner, A Haywood, TL Young, ... Clinical genetics 83 (4), 321-331, 2013 | 98 | 2013 |
| Complications associated with revision of sprint fidelis leads: report from the canadian heart rhythm society device advisory committee R Parkash, E Crystal, J Bashir, C Simpson, D Birnie, L Sterns, D Exner, ... Circulation 121 (22), 2384-2387, 2010 | 91 | 2010 |
| Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee AD Krahn, J Champagne, JS Healey, D Cameron, CS Simpson, ... Heart Rhythm 5 (5), 639-642, 2008 | 89 | 2008 |
| The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus H Milting, B Klauke, AH Christensen, J Müsebeck, V Walhorn, ... European heart journal 36 (14), 872-881, 2015 | 77 | 2015 |
| An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic … K Ng, EW Titus, KV Lieve, TM Roston, A Mazzanti, FH Deiter, I Denjoy, ... Circulation 142 (10), 932-947, 2020 | 56 | 2020 |
| Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada AFM Haywood, ND Merner, KA Hodgkinson, J Houston, P Syrris, V Booth, ... European heart journal 34 (13), 1002-1011, 2013 | 56 | 2013 |
| Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable … KA Hodgkinson, AJ Howes, P Boland, XS Shen, S Stuckless, TL Young, ... Circulation: Arrhythmia and Electrophysiology 9 (3), e003589, 2016 | 55 | 2016 |
| Failure rate of the Riata lead under advisory: a report from the CHRS Device Committee R Parkash, D Exner, J Champagne, I Mangat, B Thibault, JS Healey, ... Heart Rhythm 10 (5), 692-695, 2013 | 55 | 2013 |
| Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: results of the MORE-CRT randomized trial G Boriani, S Connors, Z Kalarus, B Lemke, W Mullens, J Osca Asensi, ... JACC: Clinical Electrophysiology 2 (2), 212-220, 2016 | 49 | 2016 |
| Bundle branch re-entrant ventricular tachycardia: novel genetic mechanisms in a life-threatening arrhythmia JD Roberts, MH Gollob, C Young, SP Connors, C Gray, SB Wilton, ... JACC: Clinical Electrophysiology 3 (3), 276-288, 2017 | 40 | 2017 |
| Management of supraventricular tachycardia in the emergency department. S Connors, P Dorian The Canadian journal of cardiology 13, 19A-24A, 1997 | 37 | 1997 |
| Exercise and arrhythmic risk in TMEM43 p. S358L arrhythmogenic right ventricular cardiomyopathy FL Paulin, KA Hodgkinson, S MacLaughlan, SN Stuckless, C Templeton, ... Heart Rhythm 17 (7), 1159-1166, 2020 | 24 | 2020 |
| Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee AD Krahn, CS Simpson, R Parkash, R Yee, J Champagne, JS Healey, ... Heart Rhythm 6 (4), 474-477, 2009 | 24 | 2009 |
| The synthesis and potassium channel blocking activity of some (4-methanesulfonamidophenoxy) propanolamines as potential class III antiarrhythmic agents SP Connors, PD Dennis, EW Gill, DA Terrar Journal of medicinal chemistry 34 (5), 1570-1577, 1991 | 24 | 1991 |
| Insight into the mechanism of failure of the Riata lead under advisory R Parkash, S Tung, J Champagne, JS Healey, B Thibault, D Cameron, ... Heart Rhythm 12 (3), 574-579, 2015 | 23 | 2015 |
